Compare EVO & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVO | VINP |
|---|---|---|
| Founded | 1993 | 2009 |
| Country | Germany | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 568.6M | 601.4M |
| IPO Year | 2007 | 2020 |
| Metric | EVO | VINP |
|---|---|---|
| Price | $1.59 | $8.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | $4.48 | ★ $12.63 |
| AVG Volume (30 Days) | 65.9K | ★ 141.8K |
| Earning Date | 11-05-2026 | 11-12-2026 |
| Dividend Yield | N/A | ★ 7.81% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $19.04 |
| Revenue Next Year | $18.90 | $11.35 |
| P/E Ratio | ★ N/A | $24.41 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.33 | $8.10 |
| 52 Week High | $3.87 | $13.61 |
| Indicator | EVO | VINP |
|---|---|---|
| Relative Strength Index (RSI) | 48.34 | 39.28 |
| Support Level | $1.50 | $8.40 |
| Resistance Level | $1.61 | $10.17 |
| Average True Range (ATR) | 0.06 | 0.43 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 28.13 | 50.16 |
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.
Vinci Compass Investments Ltd is an alternative investment platform in Brazil offering asset management, wealth management, and financial advisory services. The company comprises of six business lines i) Global IP&S, (ii) Credit (including public & private credit, opportunistic capital solutions, and agribusiness credit), (iii) Private Equity, (iv) Equities, (v) Real Assets (including real estate, infrastructure and forestry) and (vi) Corporate Advisory.